Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter, Comparative, Randomized, Double-blind, Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® in Patients With Moderate to Severe Dry Eye Syndrome

NCT03803748 is registered in ClinicalTrials.gov with SIFI SpA as lead sponsor.

NCT NCT03803748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03803748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter, Comparative, Randomized, Double-blind, Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi® in Patients With Moderate to Severe Dry Eye Syndrome
Lead sponsor
SIFI SpA
Phase
Not applicable
Overall status
Completed
Start date
July 17, 2019
Completion date
August 31, 2022
Enrollment
96 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndromes